Integrated Genomic and Epidemiological Surveillance to Monitor SARS-CoV-2 Variants in Italy: Insights From the JN.1 Case Study (2023-2024)

意大利SARS-CoV-2变异株的基因组学和流行病学综合监测:来自JN.1案例研究的启示(2023-2024)

阅读:2

Abstract

The epidemiology of SARS-CoV-2 is marked by the continuous emergence of new lineages. Early detection and assessment of their transmissibility can be challenging for surveillance systems that rely solely on case time series data. Genomic surveillance, focusing on identifying and characterizing circulating variants, can provide early insights into their epidemiological impact. Phylogenetic and phylodynamic methods were applied to sequence data collected between October 2023 and January 2024 to study the transmission of the JN.1 variant in Italy. The genomic surveillance encompassed two data flows: flash surveys estimating variant prevalence and continuous sampling to identify emerging variants. We estimated the effective reproduction number (R(e)) of JN.1 using a phylodynamic birth-death model. Results were compared with the daily net reproduction number (R(t)) of SARS-CoV-2 estimated from time series of hospital admissions recorded through epidemiological surveillance. We traced back the appearance of JN.1 in Italy to October 2023, with subvariants emerging and co-circulating shortly thereafter. JN.1 became dominant nationwide by the end of 2023. According to phylodynamic analysis, the R(e) of JN.1 was 1.73 (95% CI: 1.36-2.28) in mid-November, and its transmissibility declined over the following months. This trend aligned with R(t) estimates from epidemiological surveillance, encompassing all co-circulating lineages. The high transmissibility of JN.1 anticipated the rise in its prevalence in the population and showed a temporal correlation with a transient increase in COVID-19 hospitalizations. Integrating genomic and epidemiological surveillance enhances pathogen monitoring and the assessment of new lineages' transmissibility, providing complementary evidence to patterns observed through standard surveillance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。